No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / adverse effects
-
Adrenergic beta-Antagonists / therapeutic use
-
Aprotinin / adverse effects
-
Aprotinin / therapeutic use
-
Clinical Trials as Topic*
-
Evidence-Based Medicine*
-
Hemorrhage / therapy
-
Hemostatics / adverse effects
-
Hemostatics / therapeutic use
-
Humans
-
Perioperative Care
-
Randomized Controlled Trials as Topic
Substances
-
Adrenergic beta-Antagonists
-
Hemostatics
-
Aprotinin